[Remote] Senior Clinical Trial Manager at Abata Therapeutics

Remote

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Skills

Key technologies and capabilities for this role

Clinical Trial ManagementRegulatory ComplianceStudy PlanningOperational OversightDocumentation ReviewCross-functional Collaboration

Questions & Answers

Common questions about this position

Is this position remote, and what are the travel expectations?

The position is remote with an expectation of travel 4 days a month.

What is the salary for the Senior Clinical Trial Manager role?

This information is not specified in the job description.

What are the required qualifications or skills for this role?

This information is not specified in the job description.

What is the company culture like at Oruka Therapeutics?

The role emphasizes fostering a collaborative team environment focused on operational efficiency and continuous improvement.

What makes a strong candidate for this Senior Clinical Trial Manager position?

Strong candidates should have experience independently managing clinical trials, leading cross-functional teams, ensuring compliance with timelines and budgets, and driving operational excellence in study execution.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free